Avrobio Inc (DELISTED) (AVRO:DL)
16.80
-0.24
(-1.41%)
USD |
NASDAQ |
Jun 20, 16:00
Avrobio Market Cap: 62.85M for June 20, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
June 20, 2024 | 62.85M |
June 18, 2024 | 63.75M |
June 17, 2024 | 65.54M |
June 14, 2024 | 64.20M |
June 13, 2024 | 65.99M |
June 12, 2024 | 67.34M |
June 11, 2024 | 66.89M |
June 10, 2024 | 66.44M |
June 07, 2024 | 68.24M |
June 06, 2024 | 65.54M |
June 05, 2024 | 65.01M |
June 04, 2024 | 64.20M |
June 03, 2024 | 65.99M |
May 31, 2024 | 66.44M |
May 30, 2024 | 64.65M |
May 29, 2024 | 65.99M |
May 28, 2024 | 66.44M |
May 24, 2024 | 67.79M |
May 23, 2024 | 63.30M |
May 22, 2024 | 62.85M |
May 21, 2024 | 61.95M |
May 20, 2024 | 62.40M |
May 17, 2024 | 62.40M |
May 16, 2024 | 62.40M |
May 15, 2024 | 61.50M |
Date | Value |
---|---|
May 14, 2024 | 57.91M |
May 13, 2024 | 60.61M |
May 10, 2024 | 55.22M |
May 09, 2024 | 56.12M |
May 08, 2024 | 56.57M |
May 07, 2024 | 56.12M |
May 06, 2024 | 55.67M |
May 03, 2024 | 54.77M |
May 02, 2024 | 55.22M |
May 01, 2024 | 54.76M |
April 30, 2024 | 53.42M |
April 29, 2024 | 53.42M |
April 26, 2024 | 54.31M |
April 25, 2024 | 53.19M |
April 24, 2024 | 53.41M |
April 23, 2024 | 54.31M |
April 22, 2024 | 53.86M |
April 19, 2024 | 53.86M |
April 18, 2024 | 55.65M |
April 17, 2024 | 54.76M |
April 16, 2024 | 56.55M |
April 15, 2024 | 56.55M |
April 12, 2024 | 57.00M |
April 11, 2024 | 57.00M |
April 10, 2024 | 56.10M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
25.49M
Minimum
May 17 2023
861.00M
Maximum
Feb 11 2020
279.45M
Average
159.77M
Median
Dec 28 2021
Market Cap Benchmarks
Agenus Inc | 305.12M |
BioCryst Pharmaceuticals Inc | 1.323B |
AIM ImmunoTech Inc | 21.93M |
Protalix BioTherapeutics Inc | 76.25M |
Armata Pharmaceuticals Inc | 91.47M |
Market Cap Related Metrics
PE Ratio | 2.029 |
Price to Book Value | 0.7075 |
Price | 16.80 |
Earnings Yield | 49.29% |